← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PLIVA LACHEMA · Approved 2010-01-14

Drug application

FDA Application #

ANDA078943

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

Oxaliplatin

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

None (Tentative Approval)

Sponsor

PLIVA LACHEMA

First approval

2010-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown